AVA6103

· Avacta Life Sciences Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVA6103, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors [Phase 1]